Literature DB >> 6715799

Increased sodium-lithium countertransport in red cells of patients with Bartter's syndrome.

M Mattioli, P Delva, C Lechi, P Minuz, A Lechi, L A Scuro.   

Abstract

Erythrocyte sodium-lithium countertransport was evaluated in three adult patients with Bartter's syndrome, diagnosed on clinical and histopathological basis and on laboratory tests. As compared with age-matched control subjects, lithium effluxes to both sodium medium and to sodium-free medium were high in two patients and Na+-Li+ countertransport was significantly greater in all three patients. The relationship between increased Na+-Li+ countertransport and the proposed primary disorder of Bartter's syndrome (i.e., a primary tubular defect of chloride reabsorption) is not apparent. However, this finding favours the hypothesis of a generalized cellular membrane dysfunction of ion transport in Bartter's syndrome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6715799     DOI: 10.1007/BF03348379

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

1.  Urinary kallikrein excretion in Bartter's syndrome.

Authors:  A Lechi; G Covi; C Lechi; F Mantero; L A Scuro
Journal:  J Clin Endocrinol Metab       Date:  1976-11       Impact factor: 5.958

2.  Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin.

Authors:  R Verberckmoes; B van Damme B; J Clement; A Amery; P Michielsen
Journal:  Kidney Int       Date:  1976-03       Impact factor: 10.612

3.  Erythrocyte Na flux in a patient with Bartter's syndrome.

Authors:  G Gall; J Vaitukaitis; J E Haddow; R Klein
Journal:  J Clin Endocrinol Metab       Date:  1971-04       Impact factor: 5.958

4.  An effect of chloride on (Na+K) co-transport in human red blood cells.

Authors:  A R Chipperfield
Journal:  Nature       Date:  1980-07-17       Impact factor: 49.962

5.  Increased sodium-lithium countertransport in red cells of patients with essential hypertension.

Authors:  M Canessa; N Adragna; H S Solomon; T M Connolly; D C Tosteson
Journal:  N Engl J Med       Date:  1980-04-03       Impact factor: 91.245

6.  Bartter's syndrome: a disorder of vascular reactivity. Arthur C. Corcoran Memorial Lecture.

Authors:  F C Bartter
Journal:  Hypertension       Date:  1981 May-Jun       Impact factor: 10.190

7.  The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.

Authors:  J M Vinci; J R Gill; R E Bowden; J J Pisano; J L Izzo; N Radfar; A A Taylor; R M Zusman; F C Bartter; H R Keiser
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

8.  Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis.

Authors:  J R Gill; J C Frölich; R E Bowden; A A Taylor; H R Keiser; H W Seyberth; J A Oates; F C Bartter
Journal:  Am J Med       Date:  1976-07       Impact factor: 4.965

9.  Bartter's syndrome: contrasting patterns of prostaglandin excretion in children and adults.

Authors:  F Dray
Journal:  Clin Sci Mol Med       Date:  1978-01

10.  Sodium-lithium exchange and sodium-potassium cotransport in human erythrocytes. Part 2: A simple uptake test applied to normotensive and essential hypertensive individuals.

Authors:  J Duhm; B O Göbel; R Lorenz; P C Weber
Journal:  Hypertension       Date:  1982 Jul-Aug       Impact factor: 10.190

View more
  1 in total

1.  Angiotensin-converting enzyme inhibition as a therapeutic principle in Bartter's syndrome.

Authors:  P Jest; K E Pedersen; N A Klitgaard; N Thomsen; K Kjaer; E Simonsen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.